Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL16791 | Richard A Young | ||||||
GSE131334 |
Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance
|
87 | Richard A Young | Apr 21, 2023 | ||||
GSE223887 |
Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance [humanRibominusRNAseq]
|
6 | Richard A Young | Apr 21, 2023 | ||||
GSE223888 |
Oncogenic CDK13 Mutations Impede Nuclear RNA Surveillance [humanTTseq]
|
6 | Richard A Young | Apr 21, 2023 | ||||
GSE149085 |
Partitioning of cancer therapeutics in nuclear condensates
|
5 | Richard A Young | Apr 27, 2020 | ||||
GSE115464 |
JDP2 - an Oncogenic bZIP Transcription Factor in T-cell Acute Lymphoblastic Leukemia [RNA-Seq]
|
12 | Richard A Young | Jun 18, 2018 | ||||
GSE115465 |
JDP2 - an Oncogenic bZIP Transcription Factor in T-cell Acute Lymphoblastic Leukemia [ChIP-Seq]
|
2 | Richard A Young | Jun 18, 2018 | ||||
GSE115466 |
JDP2 - an Oncogenic bZIP Transcription Factor in T-cell Acute Lymphoblastic Leukemia
|
14 | Richard A Young | Jun 18, 2018 | ||||
GSE94822 |
Super-enhancer Driven Core Regulatory Circuitry in MYCN-amplified Neuroblastoma [ChIP-Seq]
|
16 | Richard A Young | May 22, 2018 | ||||
GSE94824 |
Super-enhancer Driven Core Regulatory Circuitry in MYCN-amplified Neuroblastoma
|
30 | Richard A Young | May 22, 2018 | ||||
GSE102684 |
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 [ChIP-seq II]
|
18 | Richard A Young | Feb 16, 2018 | ||||
GSE99518 |
YY1 is a structural regulator of enhancer-promoter loops [ChIP-Seq]
|
4 | Richard A Young | Nov 16, 2017 | ||||
GSE99519 |
YY1 is a structural regulator of enhancer-promoter loops [HiChIP]
|
17 | Richard A Young | Nov 16, 2017 | ||||
GSE99521 |
YY1 is a structural regulator of enhancer-promoter loops
|
47 | Richard A Young | Nov 16, 2017 | ||||
GSE75814 |
CDK7 Inhibition Suppresses Melanoma Growth By Depleting A Super-enhancer Associated "Achilles" Lineage Cluster [ChIP-Seq]
|
6 | Richard A Young | Oct 23, 2017 | ||||
GSE75820 |
CDK7 Inhibition Suppresses Melanoma Growth By Depleting A Super-enhancer Associated "Achilles" Lineage Cluster
|
14 | Richard A Young | Oct 23, 2017 | ||||
GSE89128 |
Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [ChIP-seq]
|
76 | Richard A Young | Oct 23, 2017 | ||||
GSE89129 |
Suppression of adaptive responses to targeted cancer therapy by transcriptional repression
|
166 | Richard A Young | Oct 23, 2017 | ||||
GSE99794 |
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors
|
8 | Richard A Young | Oct 10, 2017 | ||||
GSE94000 |
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-Cell Acute Lymphoblastic Leukemia
|
5 | Richard A Young | Mar 15, 2017 | ||||
GSE94391 |
APOBEC Signature Mutation Forms an Oncogenic Enhancer Upstream of LMO1 in T-ALL
|
1 | Richard A Young | Mar 08, 2017 |